Market Insights

The fiducial markers market was estimated at USD 113.07 million in 2021 and is likely to grow at a CAGR of 4.34% during 2022-2028 to reach USD 152.77 million in 2028.

Market Dynamics

The growing adoption of radiotherapy devices by oncologists coupled with rising cases of cancer across the globe are the prime factors augmenting the product demand. Also, the surging demand for SBRT and IGRT procedures further boosts market growth.

Moreover, increasing awareness regarding the fiducial markers to give effective diagnosis further offers lucrative opportunities to the industry players. However, the requirement of placing fiducial markers before the CT scan will necessitate a second 3D scan before or during surgery can hamper the industry expansion.

Market segmentation

Market segmentation has been done correctly to help the users define and better understand their target audiences and ideal customers. Market segmentation in this report allows you to identify the right market for your products and then target your marketing more effectively.

By product, the fiducial markers market has been categorized into gold, gold combination, polymer, other metals, and liquid.

Under these, the gold segment witnessed the highest market share in 2021 and is likely to register a significant CAGR during the review period.

This is mainly attributed to the accurate visibility and excellent stability of these products across various imaging modalities. Also, gold fiducial markers come in combination with various metals, such as platinum, titanium, and nickel, for better efficiency.

By region, the North American market garnered the largest market share in 2021 and is projected to grow at a substantial CAGR during the assessment period.

This is mainly ascribed to streamlined reimbursement policies, the strong presence of key market players, and public health programs in the region. Growing healthcare expenditure and rising adoption of advanced radiotherapy procedures & imaging modalities further boost regional growth.

Competitive landscape

Relying on data to make business decisions and to have a competitive advantage, is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the Fiducial Markers Market along with a list of Key players.

Here are few –

  • CIVCO Radiotherapy (The U.S),
  • IZI Medical Products (The U.S),
  • Naslund Medical AB (Sweden),
  • Medtronic, Inc. (Ireland),
  • QlRad Inc. (Netherlands),
  • QFix (The U.S),
  • Boston Scientific Corporation (The U.S),
  • Nanovi A/S (Denmark),
  • Eckert & Ziegler (Belgium), and
  • IBA Dosimetry GmbH (Germany).

Report Features -

This market report includes the following features –

  • Market structure: Overview, industry life cycle analysis, supply chain analysis.
  • Market environment analysis: Growth drivers and constraints.
  • Market trend and forecast analysis.
  • Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, M&As etc.
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.

Custom Research:

Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

About Stratview Research –

Stratview Research is a leading market research firm that offers wide range of services like syndicated market reports, consulting, sourcing intelligence, and customer research, etc. Stratview Research’s offerings include comprehensive market intelligence in the form of research reports, and consulting services. Our team which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 500 companies.